Reemergence of neural crest stem cell-like states in melanoma during disease progression and treatment
Open accessThe DOI matches its Crossref record; 120 of the 122 references it cites were found in a registry or an index.
Abstract
Melanoma is the deadliest of all skin cancers due to its high metastatic potential. In recent years, advances in targeted therapy and immunotherapy have contributed to a remarkable progress in the treatment of metastatic disease. However, intrinsic or acquired resistance to such therapies remains a major obstacle in melanoma treatment. Melanoma disease progression, beginning from tumor initiation and growth to acquisition of invasive phenotypes and metastatic spread and acquisition of treatment resistance, has been associated with cellular dedifferentiation and the hijacking of gene regulatory networks reminiscent of the neural crest (NC)—the developmental structure which gives rise to melanocytes and hence melanoma. This review summarizes the experimental evidence for the involvement of NC stem cell (NCSC)-like cell states during melanoma progression and addresses novel approaches to combat the emergence of stemness characteristics that have shown to be linked with aggressive disease outcome and drug resistance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“while some NCSC factors, such as SOX10 and YY1, are activated upon melanoma formation and are required for melanoma growth16,19,29,69”
From Epigenetic control of melanoma cell invasiveness by the stem cell factor SALL4 (2021) · cites this paper as [16]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Our study adds SALL4 to the growing list of stem cell factors known to control melanoma cell biology16.”
From Epigenetic control of melanoma cell invasiveness by the stem cell factor SALL4 (2021) · cites this paper as [16]
The cited source says what the claim attributes to it.
In the citing paper
“there is increasing evidence that the re-expression of NCSC-related factors can regulate melanoma initiation and later stages of the disease, such as resistance to therapies or invasion and metastatic spread16.”
From Epigenetic control of melanoma cell invasiveness by the stem cell factor SALL4 (2021) · cites this paper as [16]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Epithelial-Mesenchymal Transitions in Development and Disease
Thiery, J. P., Acloque, H., Huang, R. Y. J., & Nieto, M. A. (2009) · Cell · doi:10.1016/j.cell.2009.11.007 · Cited by 9,931
The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells
Mani, S. A., Guo, W., Liao, M.-J., Eaton, E. N., Ayyanan, A., Zhou, A. Y., Brooks, M., Reinhard, F., Zhang, C. C., Shipitsin, M., et al. (2008) · Cell · doi:10.1016/j.cell.2008.03.027 · Cited by 8,672
Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq
Tirosh, I., Izar, B., Prakadan, S. M., Wadsworth, M. H., Treacy, D., Trombetta, J. J., Rotem, A., Rodman, C., Lian, C., Murphy, G., et al. (2016) · Science · doi:10.1126/science.aad0501 · Cited by 4,944
Cancer drug resistance: an evolving paradigm
Holohan, C., Van Schaeybroeck, S., Longley, D. B., & Johnston, P. G. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3599 · Cited by 4,681
Nieto, M. A., Huang, R. Y.-J., Jackson, R. A., & Thiery, J. P. (2016) · Cell · doi:10.1016/j.cell.2016.06.028 · Cited by 4,492
Ferroptosis: past, present and future
Li, J., Cao, F., Yin, H.-L., Huang, Z.-J., Lin, Z.-T., Mao, N., Sun, B., & Wang, G. (2020) · Cell Death & Disease · doi:10.1038/s41419-020-2298-2 · Cited by 4,171
New insights into the mechanisms of epithelial–mesenchymal transition and implications for cancer
Dongre, A., & Weinberg, R. A. (2019) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-018-0080-4 · Cited by 3,876
Le Douarin, N., & Kalcheim, C. (1999) · Cambridge University Press eBooks · doi:10.1017/cbo9780511897948 · Cited by 3,014
A landscape of driver mutations in melanoma
Hodis, E., Watson, I. R., Kryukov, G. V., Arold, S. T., Imielinski, M., Theurillat, J.-P., Nickerson, E., Auclair, D., Li, L., Place, C., et al. (2012) · Cell · doi:10.1016/j.cell.2012.06.024 · Cited by 2,610
Isolation of multipotent adult stem cells from the dermis of mammalian skin
Toma, J. G., Akhavan, M., Fernandes, K. J. L., Barnabé-Heider, F., Sadikot, A., Kaplan, D. R., & Miller, F. D. (2001) · Nature Cell Biology · doi:10.1038/ncb0901-778 · Cited by 1,593
Cited by
Landscape of helper and regulatory antitumour CD4+ T cells in melanoma
Oliveira, G., Stromhaug, K., Cieri, N., Iorgulescu, J. B., Klaeger, S., Wolff, J. O., Rachimi, S., Chea, V., Krause, K., Freeman, S. S., et al. (2022) · Nature · doi:10.1038/s41586-022-04682-5 · Cited by 196
Schwann cell precursors represent a neural crest‐like state with biased multipotency
Kastriti, M. E., Faure, L., Ahsen, D. V., Bouderlique, T., Boström, J., Solovieva, T., Jackson, C. R., Bronner-Fraser, M. E., Meijer, D., Hadjab, S., et al. (2022) · The EMBO Journal · doi:10.15252/embj.2021108780 · Cited by 131
Vats, K., Kruglov, O., Sahoo, B., Soman, V., Zhang, J., Shurin, G. V., Chandran, U. R., Skums, P., Shurin, M. R., Zelikovsky, A., et al. (2022) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-22-0110 · Cited by 71
Immune escape and metastasis mechanisms in melanoma: breaking down the dichotomy
Shirley, C. A., Chhabra, G., Amiri, D., Chang, H., & Ahmad, N. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1336023 · Cited by 62
Cancer Cell Phenotype Plasticity as a Driver of Immune Escape in Melanoma
Benboubker, V., Boivin, F., Dalle, S., & Caramel, J. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.873116 · Cited by 55
Mechanisms of Melanoma Progression and Treatment Resistance: Role of Cancer Stem-like Cells
Hmada, Y. A., Brodell, R. T., Kharouf, N., Flanagan, T. W., AlAmodi, A. A., Hassan, S.-Y., Shalaby, H., Hassan, S.-L., Haïkel, Y., Megahed, M., et al. (2024) · Cancers · doi:10.3390/cancers16020470 · Cited by 48
Möller, E., Praz, V., Rajendran, S., Dong, R., Cauderay, A., Xing, Y., Lee, L., Fusco, C., Broye, L. C., Cironi, L., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-29910-4 · Cited by 48
Sanalkumar, R., Dong, R., Lee, L., Xing, Y., Iyer, S., Letovanec, I., Rosa, S. L., Finzi, G., Musolino, E., Papait, R., et al. (2023) · Science Advances · doi:10.1126/sciadv.abo3789 · Cited by 43
Melanocyte lineage dynamics in development, growth and disease
Brombin, A., & Patton, E. E. (2024) · Development · doi:10.1242/dev.201266 · Cited by 36
Tfap2b specifies an embryonic melanocyte stem cell that retains adult multifate potential
Brombin, A., Simpson, D. J., Trávníčková, J., Brunsdon, H., Zeng, Z., Lu, Y., Young, A. I. J., Chandra, T., & Patton, E. E. (2022) · Cell Reports · doi:10.1016/j.celrep.2021.110234 · Cited by 35
Epigenetic control of melanoma cell invasiveness by the stem cell factor SALL4
Diener, J., Baggiolini, A., Pernebrink, M., Dalcher, D., Lerra, L., Cheng, P. F., Varum, S., Häusel, J., Stierli, S., Treier, M., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-25326-8 · Cited by 34
Self-citationDecoding molecular programs in melanoma brain metastases
Radke, J., Schumann, E., Onken, J., Koll, R., Acker, G., Bodnar, B., Senger, C., Tierling, S., Möbs, M., Vajkoczy, P., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-34899-x · Cited by 34
Filipescu, D., Carcamo, S., Agarwal, A., Tung, N., Humblin, É., Goldberg, M. S., Vyas, N. S., Beaumont, K. G., Demircioğlu, D., Sridhar, S., et al. (2023) · Nature Cell Biology · doi:10.1038/s41556-023-01208-7 · Cited by 35
Rouanet, J., Quintana, M., Auzeloux, P., Cachin, F., & Degoul, F. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.107829 · Cited by 34
Noncoding RNA circuitry in melanoma onset, plasticity, and therapeutic response
Grafanaki, K., Grammatikakis, I., Ghosh, A., Gopalan, V., Olgun, G., Liu, H., Kyriakopoulos, G. C., Skeparnias, I., Georgiou, S., Stathopoulos, C., et al. (2023) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2023.108466 · Cited by 33
Melanoma cells repress Desmoglein 1 in keratinocytes to promote tumor cell migration
Burks, H. E., Pokorny, J. L., Koetsier, J. L., Roth‐Carter, Q. R., Arnette, C. R., Gerami, P., Seykora, J. T., Johnson, J. L., Ren, Z., & Green, K. J. (2023) · The Journal of Cell Biology · doi:10.1083/jcb.202212031 · Cited by 29
Durand, S., Tang, Y., Pommier, R. M., Benboubker, V., Grimont, M., Boivin, F., Barbollat‐Boutrand, L., Cumunel, E., Dupeuble, F., Eberhardt, A., et al. (2024) · Oncogene · doi:10.1038/s41388-024-03010-7 · Cited by 29
Katkat, E., Demirci, Y., Heger, G., Karagulle, D., Papatheodorou, I., Brāzma, A., & Özhan, G. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1297910 · Cited by 27
Hu, F., Fong, K. O., Cheung, M. P. L., Liu, J. A., Liang, R., Li, T. W., Sharma, R., Ip, P. P. C., Yang, X., & Cheung, M. C. H. (2022) · Advanced Science · doi:10.1002/advs.202105226 · Cited by 22
ALDH1A3-acetaldehyde metabolism potentiates transcriptional heterogeneity in melanoma
Lu, Y., Trávníčková, J., Badonyi, M., Rambow, F., Coates, A., Khan, Z., Júnior, J. G. M., Murphy, L. C., Garcia-Martinez, P., Marais, R., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114406 · Cited by 21
Park, M. N., Choi, J., Ribeiro, R. I. M. D. A., Delfino, D. V., Ko, S., & Kim, B. (2025) · Antioxidants · doi:10.3390/antiox14121474 · Cited by 19
Cazzato, G., Lospalluti, L., Colagrande, A., Cimmino, A., Romita, P., Foti, C., Demarco, A., Arezzo, F., Loizzi, V., Cormio, G., et al. (2021) · Dermatopathology · doi:10.3390/dermatopathology8040051 · Cited by 17
Huang, D., Kapadia, E. H., Liang, Y., Shriver, L. P., Dai, S., Patti, G. J., Humbel, B. M., Laudet, V., & Parichy, D. M. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2424180122 · Cited by 15
Aldh2 is a lineage-specific metabolic gatekeeper in melanocyte stem cells
Brunsdon, H., Brombin, A., Peterson, S. M., Postlethwait, J. H., & Patton, E. E. (2022) · Development · doi:10.1242/dev.200277 · Cited by 15
TGFβ signaling sensitizes MEKi-resistant human melanoma to targeted therapy-induced apoptosis
Loos, B., Salas-Bastos, A., Nordin, A., Debbache, J., Stierli, S., Cheng, P. F., Rufli, S., Wyss, C., Levesque, M. P., Dummer, R., et al. (2024) · Cell Death and Disease · doi:10.1038/s41419-024-07305-1 · Cited by 14
Self-citationSox9 regulates melanocytic fate decision of adult hair follicle stem cells
Stüfchen, I., Beyer, F., Staebler, S., Fischer, S., Kappelmann‐Fenzl, M., Beckervordersandforth, R., & Bosserhoff, A. (2023) · iScience · doi:10.1016/j.isci.2023.106919 · Cited by 14
Ferreres, J. R., Vinyals, A., Campos-Martín, R., Espín, R., Podlipnik, S., Ramos, R., Bertrán, E., Carrera, C., Marcoval, J., Malvehy, J., et al. (2024) · Molecular Oncology · doi:10.1002/1878-0261.13688 · Cited by 13
CXCL10 promotes melanoma angiogenesis and tumor growth
Kim, B.-J., Park, Y.-Y., & Lee, J. (2024) · Animal Cells and Systems · doi:10.1080/19768354.2024.2402024 · Cited by 13
Varrone, F., Mandrich, L., & Caputo, E. (2021) · Cancers · doi:10.3390/cancers13225788 · Cited by 13
Ladányi, A., Rásó, E., Barbai, T., Vízkeleti, L., Puskás, L. G., Kovacs, S., Győrffy, B., & Tímár, J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23052704 · Cited by 12
Antagonistic roles for MITF and TFE3 in melanoma plasticity
Chang, J., Campbell-Hanson, K. R., Vanneste, M., Bartschat, N. I., Nagel, R. H., Arnadottir, A. K., Vu, H. N., Montgomery, C., Yevdash, J. I., Jiang, J., et al. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.115474 · Cited by 11
Lencer, E. S., Rains, A. B., Binne, E., Prekeris, R., & Artinger, K. (2023) · Development · doi:10.1242/dev.201304 · Cited by 11
Dangerous liaisons: Loss of keratinocyte control over melanocytes in melanomagenesis
Green, K. J., Pokorny, J. L., & Jarrell, B. (2024) · BioEssays · doi:10.1002/bies.202400135 · Cited by 10
An in vivo avian model of human melanoma to perform rapid and robust preclinical studies
Jarrosson, L., Dalle, S., Costechareyre, C., Tang, Y., Grimont, M., Plaschka, M., Lacourrège, M., Teinturier, R., Bouar, M. L., Maucort‐Boulch, D., et al. (2023) · EMBO Molecular Medicine · doi:10.15252/emmm.202216629 · Cited by 10
Functions of LKB1 in neural crest development: The story unfolds
Thibert, C., Lucas, A., Billaud, M., Torch, S., Mével‐Aliset, M., & Allard, J. (2023) · Developmental Dynamics · doi:10.1002/dvdy.581 · Cited by 10
Peng, J., Lin, Z., Chen, W., Ruan, J., Deng, F., Yao, L., Rao, M., Xiong, X., Xu, S., Zhang, X., et al. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e17714 · Cited by 9
Giannopoulou, A. F., Velentzas, A. D., Anagnostopoulos, A. K., Agalou, A., Papandreou, N. C., Katarachia, S. A., Koumoundourou, D. G., Konstantakou, E. G., Pantazopoulou, V. I., Delis, A. D., et al. (2021) · Cancers · doi:10.3390/cancers13092024 · Cited by 8
Guendisch, U., Loos, B., Cheng, P. F., Dummer, R., Levesque, M. P., Varum, S., & Sommer, L. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.916033 · Cited by 7
Self-citationSun, Q., Wang, N., Poelchen, J., Peter, M., Novak, D., Kurt, F. G. Ö., Bitsch, R., Wu, H., Wang, Y., Pardo, S., et al. (2025) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2024-010352 · Cited by 6
Schwann cell precursors: a hub of neural crest development
Stierli, S., & Sommer, L. (2022) · The EMBO Journal · doi:10.15252/embj.2022111955 · Cited by 6
Self-citationChevalier, N. R., Gayda, F., Bondurand, N., Chan, Z. C., Savy, T., Frain, M., Merhie, A. E., Canta, L., Dicu, M., Parco, I. E.-L., et al. (2026) · Nature Communications · doi:10.1038/s41467-025-68121-5 · Cited by 5
Conway, K., Edmiston, S. N., Vondras, A. M., Reiner, A., Corcoran, D. L., Shen, R., Parrish, E., Hao, H., Lin, L., Kenney, J. M., et al. (2024) · JCO Precision Oncology · doi:10.1200/po-24-00375 · Cited by 5
Kalcheim, C. (2025) · Developmental Dynamics · doi:10.1002/dvdy.70098 · Cited by 4
Vredevoogd, D. W., & Peeper, D. S. (2021) · Science · doi:10.1126/science.abl4510 · Cited by 4
Loss of fatty acid-binding protein 7 promotes B16F10 melanoma metastasis
Wannakul, T., Miyazaki, H., Maekawa, M., Kagawa, Y., Yamamoto, Y., & Owada, Y. (2025) · Scientific Reports · doi:10.1038/s41598-024-80874-5 · Cited by 3
Papini, N., & Tringali, C. (2025) · Neuroscience · doi:10.1016/j.neuroscience.2025.10.017 · Cited by 3
In vivo DNA damage protection during cell migration across confining embryonic tissue environments
Häkkinen, H.-M., Villaseca, S., Alhashem, Z., Hamidzadeh, A., Chomiczewski, S., Desevedavy, M., Leleux, S., Liu, Y.-H., Becker, J., Htun, M. R., et al. (2026) · Nature Cell Biology · doi:10.1038/s41556-026-02065-w · Cited by 3
Liquid Biopsies: Flowing Biomarkers
Hyenne, V., Goetz, J. G., & Osmani, N. (2022) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-04039-9_14 · Cited by 3
Ge, W., Zhang, Z., Chen, W., Zhao, Z., Cai, H., Ding, Y., & Xu, J. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1662869 · Cited by 2
Neural Crest Cells: Their Multipotency and Plasticity
Motohashi, T., & Kunisada, T. (2025) · Stem Cells and Development · doi:10.1177/15473287251405289 · Cited by 2
A Melanoma-Specific Gene Network Analysis Identifies MZB1 as a Potential Tumor Promoter
Chhabra, G., Su, S., Shirley, C. A., Thornton, J., Rizvi, H. A., Robarge, R. K., Krien, J. M., Ndiaye, M. A., & Ahmad, N. (2025) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2025.07.009 · Cited by 1
Wang, N., Sun, Q., Novak, D., Zhu, L., Poelchen, J., Steinfass, T., Wang, Y., Umansky, V., & Utikal, J. S. (2025) · Molecular Oncology · doi:10.1002/1878-0261.70137 · Cited by 1
Neural crest cells hijack pluripotent stem cell factors to realize their developmental potential
Stierli, S., & Sommer, L. (2022) · Developmental Cell · doi:10.1016/j.devcel.2022.09.010 · Cited by 1
Self-citationWorley, J., Noh, H., You, D., Turunen, M. M., Ding, H., Paull, E., Griffin, A. T., Grunn, A., Zhang, M., Guillan, K. C., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.11.08.562798 · Cited by 1
Tfap2b specifies an embryonic melanocyte stem cell that retains adult multi-fate potentialPreprint
Brombin, A., Simpson, D. J., Trávníčková, J., Brunsdon, H., Zeng, Z., Lu, Y., Young, A. I. J., Chandra, T., & Patton, E. E. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.06.18.448859
Extracellular Proton Sensing GPR68 Mediates Acid Signaling in Development and CancerPreprint
Williams, C. H., Neitzel, L. R., Silver-Isenstadt, M., Mills, I. G., Ahmad, J. D., Karki, P., Chun, Y. W., Birukov, K. G., Bar, E. E., Birukova, A. A., et al. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4005577
Melanoma-associated brain metastasis: Molecular mechanisms and therapeutic options
Stejerean‐Todoran, I. (2022) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-9189
Targeting transcriptional addiction in cutaneous melanoma
Cigrang, M. (2023) · theses.fr (ABES) · doi:10.70675/32a61798z3cd7z4cd8za2acza750367acaf5
The role of ERRFI1 in melanoma progression and resistance towards targeted therapy
Wang, N. (2025) · heiDOK (Heidelberg University) · doi:10.11588/heidok.00036456
\(CDKN2A\)-dependent antigen presentation in melanoma
Wohlfarth, J. (2025) · Online Publication Service of Würzburg University (Würzburg University) · doi:10.25972/opus-35676
Sihvo, S. (2024) · UTUPub (University of Turku)
Motamedi, S. (2024) · Lirias
Fate selection in the neural crest lineage and its regulation
Akkuratova, N. (2023) · Open Archive (Karolinska Institutet)
Jiang, Y., Chen, Y., Huang, Z., Chen, L., & Huang, X. H. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27031367
Kim, J.-H., Ju, H. J., Yoo, D., Bae, J. M., Lee, S., Lee, S.-C., & Kim, K.-H. (2026) · Annals of Dermatology · doi:10.5021/ad.24.012
Wang, Q., & Wang, Y. (2026) · Pakistan Journal of Pharmaceutical Sciences · doi:10.36721/pjps.2026.39.8.213.1
Store operated Ca2+ entry in neural crest cells and their derivatives
Romito, O., & Chevalier, N. R. (2026) · Cell Calcium · doi:10.1016/j.ceca.2026.103168
SURVIVAL MODELING IN CUTANEOUS MELANOMA VIA INTEGRATIVE TRANSCRIPTOMIC AND EPIGENETIC BIOINFORMATICS
Abubakari, S. (2025) · Yildiz Technical University - AVESIS
Peripheral glia drive the initiation of cutaneous squamous cell carcinoma
Micheli, S., Salas-Bastos, A., Huỳnh, K., Cecconi, V., Kolm, I., Vasiļevska, J., Debbache, J., Renz, P. F., Diener, J., Gwerder, M., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-78778-1
Self-citationKatkat, E., Demirci, Y., Heger, G., Karagulle, D., Papatheodorou, I., Brazma, A., & Ozhan, G. (2023) · doi:10.3389/fcell.2023.1297910.s002
Metadata
- Authors
- Diener, J., & Sommer, L.
- Affiliations
- University of Zurich (CH)
- Corresponding author
- Sommer, Lukas
- Venue
- Stem Cells Translational Medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 2020-12-01
- Volume
- 10
- Issue
- 4
- Pages
- 522-533
- ISSN
- 2157-6564 (ISSN-L)
- 2157-6580
- PMC
- PMC7980219
- OpenAlex
- W3107037282
- Cited by
- 64
- References
- 122
- Citations by year
- 2026: 4 · 2025: 11 · 2024: 10 · 2023: 12 · 2022: 19 · 2021: 7 · 2020: 1
- FWCI
- 1.05
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc-nd
- creativecommons.org/licenses/by-nc-nd/4.0/ (vor, 337 d)
- creativecommons.org/licenses/by-nc-nd/4.0/ (vor)
- doi.wiley.com/10.1002/tdm_license_1.1 (tdm)
- Locations
- Stem Cells Translational Medicine (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Zurich Open Repository and Archive (University of Zurich) (acceptedVersion, cc-by-nc-nd)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Zurich Open Repository and Archive (University of Zurich) (submittedVersion, cc-by-nc-nd)
- Zurich Open Repository and Archive (University of Zurich)
- Topics
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Melanoma and MAPK Pathways
- Health Sciences › Medicine › Oncology › Cutaneous Melanoma Detection and Management
- Keywords
- melanoma, neural crest stem cells, cancer stemness, dedifferentiation, treatment resistance, metastasis, gene regulatory networks, melanocyte development, targeted therapy resistance, immunotherapy resistance, disease progression
- MeSH terms
- Humans, Melanocytes, Melanoma, Neural Crest, Disease Progression, Drug Resistance, Neoplasm, Neural Stem Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.